Yazar "Hassan, Mustafa Aziz" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Comparison of the Therapeutic Effects of Diclofenac Sodium, Prednisolone and an Alpha Blocker for the Treatment of Renal Colic
    (2012) Sümer, Alpay; Kaynar, Mehmet; Topbaş, Emrah; Hassan, Mustafa Aziz; Gürbüz, Recai
    Objective: In this study, we compare the efficacy of diclofenac sodium, methylprednisolone and alphablockers for the treatment of renal colic treatment. Material and methods: A total of 30 patients between the ages of 18-70 were included in this study. Patients were referred to the Meram Medical Faculty Urology Department or Department of Emergency Medicine at Selcuk University between October 2008 and January 2009. This prospective study was approved by the Selcuk University Meram Medical Faculty Ethics Committee. Patients were randomly divided into 3 cohorts of 10 patients each. The first group consisted of patients receiving diclofenac sodium and an alpha blocker, the second group of patients received diclofenac sodium and prednisolone, and the third group of patients received diclofenac sodium alone. Each patient was diagnosed and evaluated by the same clinician. Evaluation was based on the Numerical Classification Score (NCS) and the Renal Colic Symptom Score (RCSS). Pain intensity was evaluated prior to medication administration and 5, 10, 15, 20, and 30 hours thereafter. Statistical analysis was performed using chi-squared analysis and the Kruskal-Wallis test. Pvalue of ?0.05 were considered statistically significant. Results: Symptoms immediatiely prior to medication administration and after 5, 10, 15, 20 and 30 hours are evaluated. There are no significant differences between the groups (p>0.05). In group 1, stone expulsion occured in 4 patients (40%), a finding that is statistically significant (p=0.01). No adverse events occurred in any group during this study. Conclusion: Comparison of the therapeutic response among the 3 groups revealed no statistically significant difference. The most important aspects to consider in regard to a treatment modality include diminishing pain, dissolving blockage, a preservation of renal function and minimizing the side effects.
  • Küçük Resim
    Öğe
    Massive Haematuria Successfully Managed by Intravesical Ankaferd in a Haemodialysis Patient Complicated With Disseminated Intravascular Coagulation
    (BMJ Publishing Group, 2012) Solak, Yalçın; Gaipov, Abduzhappar; Özbek, Orhan; Hassan, Mustafa Aziz; Yeksan, Mehdi
    Massive haematuria is a life-threatening condition, demanding immediate management of bleeding. The mortality is very high in the case of delayed management of bleeding, especially in elderly patients with concomitant comorbidity. The treatment options of haematuria are wide, and depend on underlying conditions. However, therapeutic choices are limited in the presence of massive and intractable haematuria caused by disseminated intravascular coagulation (DIC). Ankaferd blood stopper (ABS) is a novel, commercially available, haemostatic agent, which has been approved by the Ministry of Health for local use in Turkey. Here, for the first time in the literature, we report a case of diffuse intravesical bleeding stopped by intravesical use of ABS in a 72-year-old man, haemodialysis patient complicated with sepsis and DIC.